Administration of antineoplastic agent via subcutaneous route   1290228009

SNOMED CT code


SNOMED code1290228009
nameAdministration of antineoplastic agent via subcutaneous route
statusactive
date introduced2023-10-01
fully specified name(s)Administration of antineoplastic agent via subcutaneous route (procedure)
synonyms
  • Subcutaneous antineoplastic chemotherapy
  • Administration of antineoplastic agent via subcutaneous route
attributes - group1
Procedure site - IndirectSubcutaneous tissue structure   71966008
Direct substanceAntineoplastic agent   372688009
Route of administrationSubcutaneous route   34206005
MethodAdministration - action   129445006
parents
  • Administration of antineoplastic agent   363688001
  • Medication administration: subcutaneous   386362006
hierarchies
a selection of possible paths
SNOMED CT Concept   138875005
  Procedure   71388002
    Procedure by method   128927009
      Introduction procedure   107733003
        Administration of medication   18629005
          Chemotherapy   367336001
            Administration of antineoplastic agent   363688001
              Administration of antineoplastic agent via subcutaneous route   1290228009

SNOMED CT Concept   138875005
  Procedure   71388002
    Procedure by method   128927009
      Introduction procedure   107733003
        Administration of medication   18629005
          Medication administration: subcutaneous   386362006
            Administration of antineoplastic agent via subcutaneous route   1290228009

ancestors
sorted most to least specific
cpt crosswalks

Rules-based maps relating CPT® codes to and from SNOMED CT® clinical concepts.  Forward and backward mapping allows for easy transition between code sets. Map-A-Code crosswalk tool easily crosswalks multiple codes between the code sets.

Access to this feature is available in the following products:
  • CPT® to SNOMED Crosswalks

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.